Phase II Study of Oral Nafithromycin in CABP
Public ClinicalTrials.gov record NCT02903836. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Double-Blind, Multicenter, Comparative Study to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Oral Nafithromycin Versus Oral Moxifloxacin in the Treatment of Community-Acquired Bacterial Pneumonia (CABP) in Adults
Study identification
- NCT ID
- NCT02903836
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Wockhardt
- Industry
- Enrollment
- 231 participants
Conditions and interventions
Interventions
- Nafithromycin 800 mg 3 days Drug
- Nafithromycin 800 mg 5 days Drug
- Moxifloxacin 400 mg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 17, 2016
- Primary completion
- Jun 30, 2017
- Completion
- Jul 7, 2017
- Last update posted
- Dec 19, 2019
2016 – 2017
United States locations
- U.S. sites
- 6
- U.S. states
- 3
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| A & L Clinical research | Miami | Florida | 33126 | — |
| A Plus Research Inc. | Miami | Florida | 33144 | — |
| RM Medical Research, Inc. | Miami | Florida | 33175 | — |
| Empire Clinical Research, LLC | Miami Lakes | Florida | 33016 | — |
| HCI Metromedic Walkin Medical Center | Bedford | Massachusetts | 02740-6634 | — |
| Health Concepts | Bedford | South Dakota | 57702 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02903836, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 19, 2019 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02903836 live on ClinicalTrials.gov.